Kancera
CEO of Novakand Pharma (formerly Kancera) leaves
Kancera seeks takeover bidder for reverse acquisition
Kancera has decided to initiate a process for...
Bioteknik
Premium
Kancera seeks interested parties for reverse acquisition
Kancera rises on positive results from the KANDOVA study
Kancera has published positive overall results from the KANDOVA study...
Bioteknik
News roundup Thursday, June 5
News roundup Tuesday, May 27
Delayed financing lowers Kancera
On Tuesday, Kancera provided an update on the collaboration...
News roundup Tuesday, May 20
News roundup Wednesday April 30
Akiram Therapeutics
News roundup Thursday, April 24
BioArctic
News roundup Tuesday, April 8
Xspray Pharma
Kancera enters into a letter of intent and changes its name
Kancera has signed a letter of intent with American Recardio...